Estonia
Lifeyear, founded in 2022, is a digital health startup headquartered in Estonia, revolutionizing cardiovascular care with its innovative remote patient management system. With the slogan, "Pioneering the next generation of digital cardiovascular care," the company seeks to address the leading cause of global mortality—cardiovascular disease—by alleviating the pressures on healthcare systems like the NHS and reducing cardiac waiting lists.
The startup's smartphone-enabled platform offers significant benefits: it optimizes care delivery for providers, simplifies remote monitoring for clinicians, and empowers patients through accessible, personalized heart care. This approach not only reduces unnecessary clinical visits and readmissions but also cuts costs and unburdens clinical teams.
Lifeyear boasts a robust team, with Dr. Eleanor Wicks providing clinical leadership and Siim Saare and Timo Mitt bringing technological expertise. Supported by Oxford University Hospitals NHS Foundation Trust, they secured a €1.50M seed investment from the Government of Estonia in June 2025. As the company scales, it presents a compelling opportunity for investors aiming to impact global health positively.
